Maker Ltd, an American Company, Acquired US$200,000 of Capital Assets on on January

question 63

Multiple Choice

Maker Ltd., an American company, acquired US$200,000 of capital assets on January 1, 2018, when the company was established. These assets were being amortized over 10 years on a straight-line basis, with no significant residual value expected. On January 1, 2019, Holdings Inc., a Canadian company with no capital assets of its own, acquired 100% of the outstanding shares of Maker. US$40,000 of the acquisition differential was allocated to the capital assets, which had eight years remaining economic life on the acquisition date. On March 1, 2020, Maker acquired a further $80,000 of capital assets, which had an estimated useful life of eight years from that date.
Exchange rates for the period from January 1, 2018 to December 31, 2020 were:
$\begin{array}{|l|r|}\hline \text { Tanuary } 1,2018 & \text { US } \$ 1.00=\text { CDN } \$ 1.05 \\\hline \text { Tanuary } 1,2019 & \text { US } \$ 1.00=\text { CDN } \$ 1.06 \\\hline \text { Average for } 2019 & \text { US } \$ 1.00=\text { CDN } \$ 1.0625 \\\hline \text { December } 31,2019 & \text { US } \$ 1.00=\text { CDN } \$ 1.065 \\\hline \text { March } 1,2020 & \text { US } \$ 1.00=\text { CDN } \$ 1.068 \\\hline \text { Average for } 2020 & \text { US } \$ 1.00=\text { CDN } \$ 1.07 \\\hline \text { December } 31,2020 & \text { US } \$ 1.00=C D N \$ 1.075\\\hline\end{array}$ If Maker's functional currency is the same as the parent's, what amount will be shown for amortization expense on its translated Canadian dollar financial statements as at December 31, 2019?

• A) $20,000
• B) $21,000
• C) $21,200
• D) $21,250

---

Definitions:

Control Group

A collection of participants in a study or experiment who do not undergo any intervention by the researchers, serving as a control to compare with the outcomes of those receiving the treatment.

Dosage Variations

Differences in the amount or concentration of a medicinal substance prescribed or administered.

Double-Blind Experiment

A study design where both the participants and the researchers are unaware of which individuals receive the treatment or the placebo, eliminating bias.

Insomnia

A common sleep disorder involving difficulty falling asleep, staying asleep, or achieving restorative sleep.